Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Status: Enrolling
Updated:  9/20/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Identification of Carotid Vasa Vasorum and Correlation With Acute Coronary Events
Status: Enrolling
Updated: 9/20/2011
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Status: Enrolling
Updated:  9/27/2011
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Status: Enrolling
Updated: 9/27/2011
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Status: Enrolling
Updated:  9/27/2011
Central MN Heart at St Cloud
mi
from
St Cloud, MN
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Status: Enrolling
Updated: 9/27/2011
Central MN Heart at St Cloud
mi
from
St Cloud, MN
Click here to add this to my saved trials
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Status: Enrolling
Updated:  9/27/2011
Sleep Therapy & Research Center, Alamo
mi
from
San Antonio, TX
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Prospective Evaluation of Heart Failure Patients With Central Sleep Apnea
Status: Enrolling
Updated: 9/27/2011
Sleep Therapy & Research Center, Alamo
mi
from
San Antonio, TX
Click here to add this to my saved trials
Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD)
Hemodynamic and Clinical Effects of Continuous Right Ventricular Pacing in the Early Post-operative Period After Left Ventricular Assist Device Implantation
Status: Enrolling
Updated:  10/4/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Right Ventricular (RV) Pacing in Early Post-operative Continuous Flow Left Ventricular Assist Device (LVAD)
Hemodynamic and Clinical Effects of Continuous Right Ventricular Pacing in the Early Post-operative Period After Left Ventricular Assist Device Implantation
Status: Enrolling
Updated: 10/4/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status: Enrolling
Updated:  10/11/2011
Georgetown University Hospital
mi
from
Washington,
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Attenuating Ischemia Reperfusion Injury After Living Donor Renal Transplantation
Status: Enrolling
Updated: 10/11/2011
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
GCC0766: Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
Status: Enrolling
Updated:  10/27/2011
University of Maryland
mi
from
Baltimore, MD
Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
GCC0766: Prevention of Anthracycline or Trastuzumab Induced Cardiomyopathy by Metoprolol
Status: Enrolling
Updated: 10/27/2011
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Roswell, GA
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Roswell, GA
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Baton Rouge, LA
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Portland, ME
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Portland, ME
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Bethesda, MD
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Grand Rapids, MI
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Rochester, MN
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Rochester, MN
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Chesterfield, MO
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Chesterfield, MO
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Cherry Hill, NJ
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
New York, NY
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Cincinnati, OH
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated:  10/27/2011
GSK Investigational Site
mi
from
Philadelphia, PA
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
Status: Enrolling
Updated: 10/27/2011
GSK Investigational Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Reminding to Improve Medication Adherence in Heart Failure
Heart iRx This Short Non-descriptive Title is the Real Title
Status: Enrolling
Updated:  10/28/2011
Akron City Hospital
mi
from
Akron, OH
Study of Reminding to Improve Medication Adherence in Heart Failure
Heart iRx This Short Non-descriptive Title is the Real Title
Status: Enrolling
Updated: 10/28/2011
Akron City Hospital
mi
from
Akron, OH
Click here to add this to my saved trials
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
REVOLUTIONARY: REtinal Vein OccLUsion Treatment With Scatter Laser Guided by Ultra Widefield angIOgraphy in combiNAtion With Ranibizumab Study Phase II
Status: Enrolling
Updated:  11/1/2011
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
REtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab Study
REVOLUTIONARY: REtinal Vein OccLUsion Treatment With Scatter Laser Guided by Ultra Widefield angIOgraphy in combiNAtion With Ranibizumab Study Phase II
Status: Enrolling
Updated: 11/1/2011
Retina Associates of Florida, P.A.
mi
from
Tampa, FL
Click here to add this to my saved trials
Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
STATUS-PCI: Stable Angina Therapy With Angiomax® or Unfractionated Heparin for patientS Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated:  11/2/2011
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention
STATUS-PCI: Stable Angina Therapy With Angiomax® or Unfractionated Heparin for patientS Undergoing Percutaneous Coronary Intervention
Status: Enrolling
Updated: 11/2/2011
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
Exploring the Effects of Tai Chi on Cardiometabolic Risk in Women
Status: Enrolling
Updated:  11/3/2011
Virginia Commonwealth University
mi
from
Richmond, VA
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
Exploring the Effects of Tai Chi on Cardiometabolic Risk in Women
Status: Enrolling
Updated: 11/3/2011
Virginia Commonwealth University
mi
from
Richmond, VA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
South Coast Retina
mi
from
Huntington Beach, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
South Coast Retina
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
South Coast Retina
mi
from
Long Beach, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
South Coast Retina
mi
from
Long Beach, CA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
Thomas Hanscom AMC
mi
from
Santa Monica, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
Thomas Hanscom AMC
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated:  11/10/2011
South Coast Retina
mi
from
Torrance, CA
Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab
Phase I/II, Open-label, Study of Intravitreal RAnibizumab 0.5MG, or High Dose 1.0mg for Retinal Vein Occlusions With rEfractory Macular Edema Previously Receiving iNtravitreal Bevacizumab (RAVEN)
Status: Enrolling
Updated: 11/10/2011
South Coast Retina
mi
from
Torrance, CA
Click here to add this to my saved trials
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
Status: Enrolling
Updated:  11/28/2011
Hartford Hospital
mi
from
Hartford, CT
The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
The Pharmacokinetics and Electrocardiographic Implications of Adjunctive Amiodarone and Ranolazine Therapy in Patients on Implantable Cardioverter Defibrillators: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot
Status: Enrolling
Updated: 11/28/2011
Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Lou Ruvo Center for Brain Health
mi
from
Las Vegas, NV
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Center for Brain Health - Mellen Center
mi
from
Cleveland, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated:  12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
Performance of AclarusDx™, A Blood-Based Transcriptomic Test for Alzheimer's Disease, in US-based Patients Suffering From Memory Impairment and Newly Referred to A Reference Memory Center, for AD Diagnostic Workup—A Pilot Descriptive Study
Status: Archived
Updated: 12/12/2011
Cleveland Clinic Senior Care Assessment - Lakewood Hospital
mi
from
Lakewood, OH
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Diagnostic Prediction Value of B Type Natriuretic Peptide (BNP) Levels in Hemodynamically Significant Patent Ductus Arteriosus (hsPDA) in Premature Infants.
Status: Enrolling
Updated:  12/21/2011
Albany Medical Center Neonatal Intesive Care Unit
mi
from
Albany, NY
Do Elevated BNP Levels Predict Hemodynamically Significant PDAs
Diagnostic Prediction Value of B Type Natriuretic Peptide (BNP) Levels in Hemodynamically Significant Patent Ductus Arteriosus (hsPDA) in Premature Infants.
Status: Enrolling
Updated: 12/21/2011
Albany Medical Center Neonatal Intesive Care Unit
mi
from
Albany, NY
Click here to add this to my saved trials
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
Genome-Wide Case-Only Study of Antihypertensive Drug-Gene Interactions
Status: Enrolling
Updated:  1/4/2012
Cardiovascular Health Research Unit
mi
from
Seattle, WA
Analyzing Gene Regions That May Interact With the Effectiveness of High Blood Pressure Drugs
Genome-Wide Case-Only Study of Antihypertensive Drug-Gene Interactions
Status: Enrolling
Updated: 1/4/2012
Cardiovascular Health Research Unit
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated:  1/6/2012
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated: 1/6/2012
Minneapolis Heart Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated:  1/6/2012
Barnes Jewish Hospital
mi
from
St. Louis, MO
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated: 1/6/2012
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated:  1/6/2012
University of Pennsylvania Presbyterian Hospital
mi
from
Philadelphia, PA
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated: 1/6/2012
University of Pennsylvania Presbyterian Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated:  1/6/2012
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair
Clinical Investigation Of The Sorin 3D Annuloplasty Ring For Mitral Repair
Status: Enrolling
Updated: 1/6/2012
The Heart Hospital Baylor Plano
mi
from
Plano, TX
Click here to add this to my saved trials
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac CT Scanning: The Multicenter ICARUS Trial
Status: Enrolling
Updated:  1/10/2012
Capital Cardiology Associates
mi
from
Albany, NY
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac CT Scanning: The Multicenter ICARUS Trial
Status: Enrolling
Updated: 1/10/2012
Capital Cardiology Associates
mi
from
Albany, NY
Click here to add this to my saved trials
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac CT Scanning: The Multicenter ICARUS Trial
Status: Enrolling
Updated:  1/10/2012
Hudson Valley Heart Center
mi
from
Poughkeepsie, NY
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac Computed Tomography (CT) Scanning
Iodine Content for Diagnostic AccuRacy and Patient Comfort For Individuals Undergoing Cardiac CT Scanning: The Multicenter ICARUS Trial
Status: Enrolling
Updated: 1/10/2012
Hudson Valley Heart Center
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
The Hypotensive Effect of Propofol: an Observational Study
The Hypotensive Effect of Propofol: an Observational Study of Hypotension With Anesthetic Induction by Propofol in the General Population Under Standard of Care Anesthesia
Status: Enrolling
Updated:  1/10/2012
The Milton S. Hershey Medical Center
mi
from
Hershey, PA
The Hypotensive Effect of Propofol: an Observational Study
The Hypotensive Effect of Propofol: an Observational Study of Hypotension With Anesthetic Induction by Propofol in the General Population Under Standard of Care Anesthesia
Status: Enrolling
Updated: 1/10/2012
The Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Aspirin Responsiveness in Women With Coronary Artery Disease
Aspirin Responsiveness in Women With Coronary Artery Disease
Status: Enrolling
Updated:  1/16/2012
The Cardiac Center at Creighton University
mi
from
Omaha, NE
Aspirin Responsiveness in Women With Coronary Artery Disease
Aspirin Responsiveness in Women With Coronary Artery Disease
Status: Enrolling
Updated: 1/16/2012
The Cardiac Center at Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Heart Failure Patient Self-Management Web Portal Pilot Study
University of Michigan Heart Failure Patient Self-Management Web Portal Pilot Study
Status: Enrolling
Updated:  1/17/2012
University of Michigan Cardiovascular Center
mi
from
Ann Arbor, MI
Heart Failure Patient Self-Management Web Portal Pilot Study
University of Michigan Heart Failure Patient Self-Management Web Portal Pilot Study
Status: Enrolling
Updated: 1/17/2012
University of Michigan Cardiovascular Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Heart Failure Patient Self-Management Web Portal Pilot Study
University of Michigan Heart Failure Patient Self-Management Web Portal Pilot Study
Status: Enrolling
Updated:  1/17/2012
University of Michigan Cardiovascular Center
mi
from
Ann Arbor, MI
Heart Failure Patient Self-Management Web Portal Pilot Study
University of Michigan Heart Failure Patient Self-Management Web Portal Pilot Study
Status: Enrolling
Updated: 1/17/2012
University of Michigan Cardiovascular Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Abdominal Compression in Orthostatic Hypotension
The Efficacy of Adjustable Lower Abdominal Compression in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated:  1/17/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Abdominal Compression in Orthostatic Hypotension
The Efficacy of Adjustable Lower Abdominal Compression in Neurogenic Orthostatic Hypotension
Status: Enrolling
Updated: 1/17/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis
Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, D-dimer Test and Ultrasonography in Suspected Upper Extremity Deep Vein Thrombosis: a Prospective Management Study
Status: Enrolling
Updated:  1/18/2012
Veterans Affairs Hospital
mi
from
Washington D.C.,
Diagnostic Algorithm in Suspected Upper Extremity Deep Vein Thrombosis
Safety and Feasibility of a Diagnostic Algorithm Combining Clinical Probability, D-dimer Test and Ultrasonography in Suspected Upper Extremity Deep Vein Thrombosis: a Prospective Management Study
Status: Enrolling
Updated: 1/18/2012
Veterans Affairs Hospital
mi
from
Washington D.C.,
Click here to add this to my saved trials
Sickle Cell Trait and the Risk of Venous Thromboembolism
Sickle Cell Trait and the Risk of Venous Thromboembolism
Status: Enrolling
Updated:  2/2/2012
Montefiore Medical Center (Einstein)
mi
from
Bronx, NY
Sickle Cell Trait and the Risk of Venous Thromboembolism
Sickle Cell Trait and the Risk of Venous Thromboembolism
Status: Enrolling
Updated: 2/2/2012
Montefiore Medical Center (Einstein)
mi
from
Bronx, NY
Click here to add this to my saved trials
CoQ10 Biomarker Trial
Assessing the Effect of the Dietary Supplement Coenzyme Q10 on Biomarkers of Oxidative Stress, Systemic Inflammation, and Endothelial Function in Hemodialysis Patients
Status: Enrolling
Updated:  2/3/2012
Northwest Kidney Centers
mi
from
Seattle, WA
CoQ10 Biomarker Trial
Assessing the Effect of the Dietary Supplement Coenzyme Q10 on Biomarkers of Oxidative Stress, Systemic Inflammation, and Endothelial Function in Hemodialysis Patients
Status: Enrolling
Updated: 2/3/2012
Northwest Kidney Centers
mi
from
Seattle, WA
Click here to add this to my saved trials
Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia
Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia
Status: Enrolling
Updated:  2/6/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia
Dexmedetomidine Versus Adenosine: Electrophysiologic Effects and Therapeutic Use for Terminating Supraventricular Tachycardia
Status: Enrolling
Updated: 2/6/2012
Children's Hospital of Pittsburgh of UPMC
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
T-wave Alternans and Intrathoracic Impedance Measurements
T-wave Alternans and Intrathoracic Impedance Measurements
Status: Enrolling
Updated:  2/8/2012
Columbia University Medical Center
mi
from
New York, NY
T-wave Alternans and Intrathoracic Impedance Measurements
T-wave Alternans and Intrathoracic Impedance Measurements
Status: Enrolling
Updated: 2/8/2012
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Optimized Biventricular Pacing Allograft Recipients
Optimized Biventricular Pacing in Allograft Recipients
Status: Enrolling
Updated:  2/14/2012
Columbia University Medial Center
mi
from
New York, NY
Optimized Biventricular Pacing Allograft Recipients
Optimized Biventricular Pacing in Allograft Recipients
Status: Enrolling
Updated: 2/14/2012
Columbia University Medial Center
mi
from
New York, NY
Click here to add this to my saved trials
REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts
Status: Enrolling
Updated:  2/15/2012
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
REgenerative CardiOsphere iNjection to STRengthen dysfUnCTional Hearts
Status: Enrolling
Updated: 2/15/2012
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials